T1	Participants 16 53	advanced gastric carcinoma (stage IV)
T2	Participants 105 277	Forty-six patients with advanced gastric carcinoma (Stage IV) were evaluated in a prospective randomized comparison of two chemotherapy regimens (FAM versus 5-FU plus BCNU)
